The Scripps Research Institute, Jupiter, FL 33458, USA.
Trends Endocrinol Metab. 2012 Dec;23(12):619-27. doi: 10.1016/j.tem.2012.05.012. Epub 2012 Jul 11.
The retinoic-acid-receptor-related orphan receptors (RORs) are members of the nuclear receptor (NR) superfamily whose activity has been implicated in several physiological and pathological processes. The RORs, specifically RORα and RORγ, are considered to be master regulators of T(H)17 cells, a recently described subset of CD4(+) T helper cells that have been demonstrated to have a pathological role in autoimmune disease. As with most members of the NR superfamily, RORs are ligand-regulated, suggesting that their activity can be modulated by synthetic ligands. Recent advances in the field have established that selective inhibition of the RORs is a viable therapeutic approach for not only the treatment of autoimmune disorders but also ROR-mediated metabolic disorders.
维甲酸受体相关孤儿受体(RORs)是核受体(NR)超家族的成员,其活性被认为与多种生理和病理过程有关。RORs,特别是 RORα 和 RORγ,被认为是 T(H)17 细胞的主要调节因子,T(H)17 细胞是最近描述的 CD4(+)辅助性 T 细胞亚群,已被证明在自身免疫性疾病中具有病理作用。与 NR 超家族的大多数成员一样,RORs 是配体调节的,这表明它们的活性可以通过合成配体来调节。该领域的最新进展表明,ROR 选择性抑制不仅是治疗自身免疫性疾病的可行治疗方法,也是 ROR 介导的代谢紊乱的可行治疗方法。